Does GEFITINIB Cause Neoplasm progression? 67 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 67 reports of Neoplasm progression have been filed in association with GEFITINIB (Gefitinib). This represents 1.4% of all adverse event reports for GEFITINIB.
67
Reports of Neoplasm progression with GEFITINIB
1.4%
of all GEFITINIB reports
16
Deaths
15
Hospitalizations
How Dangerous Is Neoplasm progression From GEFITINIB?
Of the 67 reports, 16 (23.9%) resulted in death, 15 (22.4%) required hospitalization, and 2 (3.0%) were considered life-threatening.
Is Neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GEFITINIB. However, 67 reports have been filed with the FAERS database.
What Other Side Effects Does GEFITINIB Cause?
Malignant neoplasm progression (1,651)
Drug resistance (1,228)
Death (590)
Diarrhoea (393)
Rash (318)
Metastases to central nervous system (306)
Acquired gene mutation (250)
Disease progression (244)
Drug ineffective (197)
Off label use (166)
What Other Drugs Cause Neoplasm progression?
PALBOCICLIB (10,885)
SUNITINIB MALATE (1,920)
CYCLOPHOSPHAMIDE (1,588)
CARBOPLATIN (1,370)
AXITINIB (1,315)
DOXORUBICIN (1,276)
LETROZOLE (1,225)
PACLITAXEL (1,180)
CRIZOTINIB (1,161)
VINCRISTINE (1,106)
Which GEFITINIB Alternatives Have Lower Neoplasm progression Risk?
GEFITINIB vs GELATIN
GEFITINIB vs GEMCITABINE
GEFITINIB vs GEMCITABINE\GEMCITABINE
GEFITINIB vs GEMFIBROZIL
GEFITINIB vs GEMTUZUMAB OZOGAMICIN